Trial reportObesity surgery2026
Comparison of Erector Spinae Plane Block and Intravenous Lidocaine in Opioid-Free Anesthesia for Laparoscopic Sleeve Gastrectomy: A Randomized Controlled Trial.
Trial report in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
introductionOpioid-free anesthesia (OFA) protocols are increasingly adopted in metabolic and bariatric surgery to minimize opioid-related complications. Both erector spinae plane block (ESPB) and intravenous (IV) lidocaine have demonstrated analgesic efficacy in various surgical settings, but direct comparisons in an OFA framework for metabolic and bariatric procedures remain limited.
methodsWe conducted a prospective, randomized controlled trial comparing ESPB with IV lidocaine in adults with obesity (BMI ≥ 35 kg/m²) undergoing laparoscopic sleeve gastrectomy under OFA. Patients were randomized 1:1 to receive either bilateral ultrasound-guided ESPB before induction or an intraoperative lidocaine infusion. All patients received standardized multimodal analgesia. The primary outcome was total opioid consumption during the first 24 h postoperatively, expressed in IV oxycodone equivalents. Secondary outcomes included pain scores (NRS), intraoperative rescue medication, postoperative nausea and vomiting (PONV), and recovery parameters. Analyses were conducted on a modified intention-to-treat basis.
resultsA total of 277 patients were included in the analysis (136 in the ESPB group and 141 in the lidocaine group). The ESPB group demonstrated significantly lower median opioid consumption within the first 24 h postoperatively (2.0 mg vs. 2.5 mg; p = 0.048). Opioid-free recovery (0 mg IV oxycodone equivalents within 24 h) occurred in 47.1% of patients in the ESPB group and 39.0% in the lidocaine group (p = 0.176). NRS scores did not differ significantly between the groups at any assessed time point. Incidences of intraoperative hemodynamic instability, rescue medication use, delayed emergence, and PONV were similar. No serious adverse events or complications related to the block were reported.
conclusionIn the context of OFA for laparoscopic sleeve gastrectomy, both ESPB and intravenous lidocaine were safe and effective analgesic options. ESPB was associated with a statistically significant but clinically modest reduction in 24-hour opioid consumption, while pain scores and recovery outcomes were comparable. Both techniques can therefore be considered appropriate components of OFA, and the choice may depend on patient characteristics, institutional logistics, and anesthesiologist expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.